| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.XPHS.2020.10.019 |
| P698 | PubMed publication ID | 33069708 |
| P2093 | author name string | Pierre Cuq | |
| Jean-Marie Devoisselle | |||
| Anne Aubert-Pouëssel | |||
| Nicolas Masurier | |||
| Koceïla Doufène | |||
| Laure-Anaïs Vincent | |||
| Yohan Malki | |||
| P2860 | cites work | Computation of octanol-water partition coefficients by guiding an additive model with knowledge | Q28256418 |
| Selective C-acylation of 2-aminoimidazo[1,2-a]pyridine: application to the synthesis of imidazopyridine-fused [1,3]diazepinones | Q34197965 | ||
| The role of BRAF V600 mutation in melanoma | Q34637951 | ||
| NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel | Q36616645 | ||
| Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems | Q38051448 | ||
| Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells. | Q38729830 | ||
| The global burden of melanoma: results from the Global Burden of Disease Study 2015. | Q38859896 | ||
| Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity. | Q39021626 | ||
| Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies | Q39263714 | ||
| Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles | Q39759742 | ||
| Fluorescent property of 3-hydroxymethyl imidazo[1,2-a]pyridine and pyrimidine derivatives. | Q42617371 | ||
| Preparation and characterization of solid lipid nanospheres containing paclitaxel | Q43464750 | ||
| Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response | Q53414165 | ||
| Understanding the Challenge of Beyond-Rule-of-5 Compounds. | Q54191018 | ||
| Dry Hybrid Lipid−Silica Microcapsules Engineered from Submicron Lipid Droplets and Nanoparticles as a Novel Delivery System for Poorly Soluble Drugs | Q59234601 | ||
| Targeting the ERK Signaling Pathway in Melanoma | Q64055352 | ||
| A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma | Q80224592 | ||
| New opportunities with the Duff reaction | Q81571090 | ||
| Intratumoral administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumor | Q88299761 | ||
| Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics | Q89917292 | ||
| A Rational Design of a Biphasic DissolutionSetup-Modelling of Biorelevant Kinetics for a Ritonavir Hot-Melt Extruded Amorphous Solid Dispersion | Q90191794 | ||
| Tumor targeting via EPR: Strategies to enhance patient responses | Q90229748 | ||
| Melanoma treatment: from conventional to nanotechnology | Q90863671 | ||
| Advanced stage melanoma therapies: Detailing the present and exploring the future | Q91129002 | ||
| Novel Targets for the Treatment of Melanoma | Q91157777 | ||
| Tunable vegetable oil/silica hybrid microparticles for poorly water-soluble drug delivery | Q91511481 | ||
| Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity | Q91582300 | ||
| P577 | publication date | 2020-10-15 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Vegetable Oil-basedHybrid Submicron Particles Loaded with JMV5038: A Promising Formulation against Melanoma |
Search more.